JAC Advance Access published online on August 10, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl330
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory Medicine Services, Changi General Hospital, 2 Simei Street 3, Singapore 529889
* To whom correspondence should be addressed. Objectives: With increasing antibiotic resistance in Gram-negative bacteria, the use of the polymyxins has increased in recent years. Antibiotic disc susceptibility testing remains the most widely used method in clinical laboratories, but there is very little data on the accuracy of disc testing methods for colistin. In this study, the accuracy of three standardized methods of disc susceptibility testing for colistin was compared with agar dilution. Methods: A total of 228 clinical isolates of Acinetobacter spp., Pseudomonas aeruginosa and Enterobacteriaceae were included in the study. Isolates were tested by agar dilution for susceptibility to colistin, and results were compared with those obtained by three disc susceptibility testing methods (product insert based on CLSI methodology, British BSAC and French SFM). Results: Colistin displayed good activity against Acinetobacter spp., Klebsiella spp. and Escherichia coli (MIC90 2 mg/L) but was less active against P. aeruginosa (MIC90 4 mg/L) and Enterobacter spp. (MIC90 Conclusions: Disc susceptibility testing methods are unreliable at detecting colistin resistance. Dilution methods should be the method of choice for susceptibility testing of colistin.
Received May 14, 2006
Revised July 18, 2006
Accepted July 18, 2006
Brief report
Comparison of three standardized disc susceptibility testing methods for colistin
Thean Yen Tan 1 * and Lily Siew Yong Ng 1
Thean Yen Tan, E-mail: thean_yen_tan{at}cgh.com.sg
![]()
Abstract
128 mg/L). Totally, 81%, 79% and 89% of colistin-resistant isolates were falsely reported as susceptible when tested by the product insert, BSAC and SFM testing methods, respectively. There were no false-resistant results.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Landman, C. Georgescu, D. A. Martin, and J. Quale Polymyxins Revisited Clin. Microbiol. Rev., July 1, 2008; 21(3): 449 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Peleg, H. Seifert, and D. L. Paterson Acinetobacter baumannii: Emergence of a Successful Pathogen Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Perez, A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo Global Challenge of Multidrug-Resistant Acinetobacter baumannii Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3471 - 3484. [Full Text] [PDF] |
||||
![]() |
J. R. Lo-Ten-Foe, A. M. G. A. de Smet, B. M. W. Diederen, J. A. J. W. Kluytmans, and P. H. J. van Keulen Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3726 - 3730. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Goldstein, A. Ly, and M. D. Kitzis Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin J. Antimicrob. Chemother., May 1, 2007; 59(5): 1039 - 1040. [Full Text] [PDF] |
||||


